By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Kyorin Pharmaceutical Co., Ltd. 

5, Kanda Surugadai 2-chome
Chiyoda-ku
Tokyo    101  Japan
Phone: Fax:


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Eisai Company, Ltd. (ESALY.PK) And Kyorin Pharmaceutical Co., Ltd. Enter Into Agreement Concerning Compound Library Use For The Development Of New Antibacterial Agents 9/19/2014 7:32:52 AM
Kyorin Pharmaceutical Co., Ltd. and BioLeap Enter Research Collaboration 1/9/2012 6:30:16 AM
Kyorin Pharmaceutical Co., Ltd. and Eisai Company, Ltd. (ESALY.PK) Sign License Agreement for Development and Marketing of Uritos(R) Tablets in China, India, Sri Lanka and ASEAN Countries 9/29/2009 10:31:59 AM
Skyepharma PLC (SKYE) Announces Exclusive License Agreement with Kyorin Pharmaceutical Co., Ltd. for Development and Distribution of Flutiform(TM) in Japan 4/22/2008 10:20:58 AM
Bristol-Myers Squibb Company (BMY) To Stop Sale, Manufacture Of Antibiotic Tequin 5/2/2006 11:15:39 AM
Kyorin Pharmaceutical Co., Ltd. To Reorganize Its Group Businesses In October 4/21/2006 10:33:53 AM
ActivX Biosciences, Inc./Kyorin Pharmaceutical Co., Ltd. Begins First U.S. Phase I Study For Novel Anti-Diabetic Drug 3/15/2006 10:19:54 AM
Kyorin Pharmaceutical Co., Ltd. Licenses Immunosuppressant Drug To Novartis Corporation (NVS) 2/16/2006 10:23:43 AM
Dainippon Pharmaceutical And Kyorin Pharmaceutical Co., Ltd. To Collaborate In Development Of Drug Candidate For Diabetic Complication10/19/2005 5:13:06 PM
ActivX Biosciences, Inc. Announces Expansion Of Strategic Collaboration Agreement With Pfizer Inc. (PFE) With Multiple Discovery And Developmental Stage Projects10/19/2005 5:12:40 PM
123
//-->